{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:07:50Z","timestamp":1759226870895},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>This study was designed to investigate, for the first time, the short-term molecular evolution of the HIV-2 C2, V3 and C3 envelope regions and its association with the immune response. Clonal sequences of the<jats:italic>env<\/jats:italic>C2V3C3 region were obtained from a cohort of eighteen HIV-2 chronically infected patients followed prospectively during 2\u20134 years. Genetic diversity, divergence, positive selection and glycosylation in the C2V3C3 region were analysed as a function of the number of CD4+ T cells and the anti-C2V3C3 IgG and IgA antibody reactivity<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean intra-host nucleotide diversity was 2.1% (SD, 1.1%), increasing along the course of infection in most patients. Diversity at the amino acid level was significantly lower for the V3 region and higher for the C2 region. The average divergence rate was 0.014 substitutions\/site\/year, which is similar to that reported in chronic HIV-1 infection. The number and position of positively selected sites was highly variable, except for codons 267 and 270 in C2 that were under strong and persistent positive selection in most patients. N-glycosylation sites located in C2 and V3 were conserved in all patients along the course of infection. Intra-host variation of C2V3C3-specific IgG response over time was inversely associated with the variation in nucleotide and amino acid diversity of the C2V3C3 region. Variation of the C2V3C3-specific IgA response was inversely associated with variation in the number of N-glycosylation sites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The evolutionary dynamics of HIV-2 envelope during chronic aviremic infection is similar to HIV-1 implying that the virus should be actively replicating in cellular compartments. Convergent evolution of N-glycosylation in C2 and V3, and the limited diversification of V3, indicates that there are important functional constraints to the potential diversity of the HIV-2 envelope. C2V3C3-specific IgG antibodies are effective at reducing viral population size limiting the number of virus escape mutants. The C3 region seems to be a target for IgA antibodies and increasing N-linked glycosylation may prevent HIV-2 envelope recognition by these antibodies. Our results provide new insights into the biology of HIV-2 and its relation with the human host and may have important implications for vaccine design.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1742-4690-5-78","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T06:14:06Z","timestamp":1220940846000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients"],"prefix":"10.1186","volume":"5","author":[{"given":"Pedro","family":"Borrego","sequence":"first","affiliation":[]},{"given":"Jos\u00e9 Maria","family":"Marcelino","sequence":"additional","affiliation":[]},{"given":"Cheila","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Doroana","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Maltez","sequence":"additional","affiliation":[]},{"given":"Perp\u00e9tua","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Novo","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Barroso","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,9,8]]},"reference":[{"key":"903_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/jama.1996.03530270050031","volume":"275","author":"DJ Hu","year":"1996","unstructured":"Hu DJ, Dondero TJ, Rayfield MA, George JR, Schochetman G, Jaffe HW, Luo CC, Kalish ML, Weniger BG, Pau CP, et al: The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA. 1996, 275: 210-216. 10.1001\/jama.275.3.210.","journal-title":"JAMA"},{"key":"903_CR2","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1001\/archinte.160.21.3286","volume":"160","author":"S Andersson","year":"2000","unstructured":"Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S, Christopherson C, Biberfeld G, Albert J: Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med. 2000, 160: 3286-3293. 10.1001\/archinte.160.21.3286.","journal-title":"Arch Intern Med"},{"key":"903_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S0140-6736(94)90065-5","volume":"343","author":"PJ Kanki","year":"1994","unstructured":"Kanki PJ, Travers KU, S MB, Hsieh CC, Marlink RG, Gueye NA, Siby T, Thior I, Hernandez-Avila M, Sankale JL, et al: Slower heterosexual spread of HIV-2 than HIV-1. Lancet. 1994, 343: 943-946. 10.1016\/S0140-6736(94)90065-5.","journal-title":"Lancet"},{"key":"903_CR4","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1126\/science.7915856","volume":"265","author":"R Marlink","year":"1994","unstructured":"Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, et al: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994, 265: 1587-1590. 10.1126\/science.7915856.","journal-title":"Science"},{"key":"903_CR5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1097\/00002030-199411000-00015","volume":"8","author":"H Whittle","year":"1994","unstructured":"Whittle H, Morris J, Todd J, Corrah T, Sabally S, Bangali J, Ngom PT, Rolfe M, Wilkins A: HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS. 1994, 8: 1617-1620. 10.1097\/00002030-199411000-00015.","journal-title":"AIDS"},{"key":"903_CR6","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1099\/0022-1317-83-6-1253","volume":"83","author":"JD Reeves","year":"2002","unstructured":"Reeves JD, Doms RW: Human immunodeficiency virus type 2. J Gen Virol. 2002, 83: 1253-1265.","journal-title":"J Gen Virol"},{"key":"903_CR7","first-page":"457","volume":"1","author":"N Berry","year":"1998","unstructured":"Berry N, Ariyoshi K, Jaffar S, Sabally S, Corrah T, Tedder R, Whittle H: Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol. 1998, 1: 457-468.","journal-title":"J Hum Virol"},{"key":"903_CR8","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1128\/JVI.01557-06","volume":"80","author":"R Soares","year":"2006","unstructured":"Soares R, Foxall R, Albuquerque A, Cortesao C, Garcia M, Victorino RM, Sousa AE: Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection. J Virol. 2006, 80: 12425-12429. 10.1128\/JVI.01557-06.","journal-title":"J Virol"},{"key":"903_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1089\/vim.2004.17.436","volume":"17","author":"DE Anderson","year":"2004","unstructured":"Anderson DE, Llenado RA, Torres JV: Humoral immunity and the evolution of HIV-2. Viral Immunol. 2004, 17: 436-439. 10.1089\/vim.2004.17.436.","journal-title":"Viral Immunol"},{"key":"903_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/08892220260387904","volume":"18","author":"N Berry","year":"2002","unstructured":"Berry N, Jaffar S, Schim van der Loeff M, Ariyoshi K, Harding E, N'Gom PT, Dias F, Wilkins A, Ricard D, Aaby P, et al: Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res Hum Retroviruses. 2002, 18: 1167-1173. 10.1089\/08892220260387904.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"903_CR11","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1128\/JVI.78.13.7016-7022.2004","volume":"78","author":"Q Lizeng","year":"2004","unstructured":"Lizeng Q, Nilsson C, Sourial S, Andersson S, Larsen O, Aaby P, Ehnlund M, Bjorling E: Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals. J Virol. 2004, 78: 7016-7022. 10.1128\/JVI.78.13.7016-7022.2004.","journal-title":"J Virol"},{"key":"903_CR12","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1128\/JVI.02625-06","volume":"81","author":"A MacNeil","year":"2007","unstructured":"MacNeil A, Sarr AD, Sankale JL, Meloni ST, Mboup S, Kanki P: Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol. 2007, 81: 5325-5330. 10.1128\/JVI.02625-06.","journal-title":"J Virol"},{"key":"903_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.virol.2006.05.029","volume":"353","author":"H Blaak","year":"2006","unstructured":"Blaak H, Ende van der ME, Boers PH, Schuitemaker H, Osterhaus AD: In vitro replication capacity of HIV-2 variants from long-term aviremic individuals. Virology. 2006, 353: 144-154. 10.1016\/j.virol.2006.05.029.","journal-title":"Virology"},{"key":"903_CR14","volume-title":"HIV and the pathogenesis of AIDS","author":"JA Levy","year":"1998","unstructured":"Levy JA: HIV and the pathogenesis of AIDS. 1998, Washington, D.C.: ASM Press, 2","edition":"2"},{"key":"903_CR15","first-page":"125","volume":"8","author":"P Lemey","year":"2006","unstructured":"Lemey P, Rambaut A, Pybus OG: HIV evolutionary dynamics within and among hosts. AIDS Rev. 2006, 8: 125-140.","journal-title":"AIDS Rev"},{"key":"903_CR16","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/jvi.71.10.7498-7508.1997","volume":"71","author":"EL Delwart","year":"1997","unstructured":"Delwart EL, Pan H, Sheppard HW, Wolpert D, Neumann AU, Korber B, Mullins JI: Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J Virol. 1997, 71: 7498-7508.","journal-title":"J Virol"},{"key":"903_CR17","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1128\/JVI.73.12.10489-10502.1999","volume":"73","author":"R Shankarappa","year":"1999","unstructured":"Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, et al: Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol. 1999, 73: 10489-10502.","journal-title":"J Virol"},{"key":"903_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/molbev\/msi029","volume":"22","author":"S Williamson","year":"2005","unstructured":"Williamson S, Perry SM, Bustamante CD, Orive ME, Stearns MN, Kelly JK: A statistical characterization of consistent patterns of human immunodeficiency virus evolution within infected patients. Mol Biol Evol. 2005, 22: 456-468. 10.1093\/molbev\/msi029.","journal-title":"Mol Biol Evol"},{"key":"903_CR19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1089\/aid.2004.20.1314","volume":"20","author":"F Castiglione","year":"2004","unstructured":"Castiglione F, Poccia F, D'Offizi G, Bernaschi M: Mutation, fitness, viral diversity, and predictive markers of disease progression in a computational model of HIV type 1 infection. AIDS Res Hum Retroviruses. 2004, 20: 1314-1323. 10.1089\/aid.2004.20.1314.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"903_CR20","doi-asserted-by":"publisher","first-page":"12568","DOI":"10.1073\/pnas.95.21.12568","volume":"95","author":"RB Markham","year":"1998","unstructured":"Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu XF: Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci USA. 1998, 95: 12568-12573. 10.1073\/pnas.95.21.12568.","journal-title":"Proc Natl Acad Sci USA"},{"key":"903_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1089\/aid.2007.0074","volume":"23","author":"G Bello","year":"2007","unstructured":"Bello G, Casado C, Sandonis V, Alvaro-Cifuentes T, Dos Santos CA, Garcia S, Rodriguez C, Del Romero J, Pilotto JH, Grinsztejn B, et al: Plasma viral load threshold for sustaining intrahost HIV type 1 evolution. AIDS Res Hum Retroviruses. 2007, 23: 1242-1250. 10.1089\/aid.2007.0074.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"903_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.meegid.2004.07.008","volume":"5","author":"H Barroso","year":"2005","unstructured":"Barroso H, Taveira N: Evidence for negative selective pressure in HIV-2 evolution in vivo. Infect Genet Evol. 2005, 5: 239-246. 10.1016\/j.meegid.2004.07.008.","journal-title":"Infect Genet Evol"},{"key":"903_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/aid.1995.11.617","volume":"11","author":"JL Sankale","year":"1995","unstructured":"Sankale JL, de la Tour RS, Renjifo B, Siby T, Mboup S, Marlink RG, Essex ME, Kanki PJ: Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res Hum Retroviruses. 1995, 11: 617-623.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"903_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1086\/511308","volume":"195","author":"A MacNeil","year":"2007","unstructured":"MacNeil A, Sankale JL, Meloni ST, Sarr AD, Mboup S, Kanki P: Long-term intrapatient viral evolution during HIV-2 infection. J Infect Dis. 2007, 195: 726-733. 10.1086\/511308.","journal-title":"J Infect Dis"},{"key":"903_CR25","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1128\/JVI.78.4.1962-1970.2004","volume":"78","author":"M Choisy","year":"2004","unstructured":"Choisy M, Woelk CH, Guegan JF, Robertson DL: Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol. 2004, 78: 1962-1970. 10.1128\/JVI.78.4.1962-1970.2004.","journal-title":"J Virol"},{"key":"903_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-4690-2-41","volume":"2","author":"M Mikhail","year":"2005","unstructured":"Mikhail M, Wang B, Lemey P, Beckthold B, Vandamme AM, Gill MJ, Saksena NK: Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort. Retrovirology. 2005, 2: 41-10.1186\/1742-4690-2-41.","journal-title":"Retrovirology"},{"key":"903_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1073\/pnas.94.4.1264","volume":"94","author":"Y Yamaguchi","year":"1997","unstructured":"Yamaguchi Y, Gojobori T: Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc Natl Acad Sci USA. 1997, 94: 1264-1269. 10.1073\/pnas.94.4.1264.","journal-title":"Proc Natl Acad Sci USA"},{"key":"903_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1742-4690-2-67","volume":"2","author":"H Zhang","year":"2005","unstructured":"Zhang H, Hoffmann F, He J, He X, Kankasa C, Ruprecht R, West JT, Orti G, Wood C: Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant. Retrovirology. 2005, 2: 67-10.1186\/1742-4690-2-67.","journal-title":"Retrovirology"},{"key":"903_CR29","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/jvi.66.11.6777-6780.1992","volume":"66","author":"JJ De Jong","year":"1992","unstructured":"De Jong JJ, De Ronde A, Keulen W, Tersmette M, Goudsmit J: Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol. 1992, 66: 6777-6780.","journal-title":"J Virol"},{"key":"903_CR30","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1128\/JCM.02090-06","volume":"45","author":"P Delobel","year":"2007","unstructured":"Delobel P, Nugeyre MT, Cazabat M, Pasquier C, Marchou B, Massip P, Barre-Sinoussi F, Israel N, Izopet J: Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies. J Clin Microbiol. 2007, 45: 1572-1580. 10.1128\/JCM.02090-06.","journal-title":"J Clin Microbiol"},{"key":"903_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1126\/science.1118398","volume":"310","author":"CC Huang","year":"2005","unstructured":"Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL, Dimitrov DS, Korber B, Sodroski J, Wilson IA, et al: Structure of a V3-containing HIV-1 gp120 core. Science. 2005, 310: 1025-1028. 10.1126\/science.1118398.","journal-title":"Science"},{"key":"903_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/viro.1999.0006","volume":"264","author":"Y Isaka","year":"1999","unstructured":"Isaka Y, Sato A, Miki S, Kawauchi S, Sakaida H, Hori T, Uchiyama T, Adachi A, Hayami M, Fujiwara T, Yoshie O: Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5. Virology. 1999, 264: 237-243. 10.1006\/viro.1999.0006.","journal-title":"Virology"},{"key":"903_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/HAB-2005-143-403","volume":"14","author":"S Zolla-Pazner","year":"2005","unstructured":"Zolla-Pazner S: Improving on nature: focusing the immune response on the V3 loop. Hum Antibodies. 2005, 14: 69-72.","journal-title":"Hum Antibodies"},{"key":"903_CR34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1006\/viro.1993.1160","volume":"193","author":"E Bjorling","year":"1993","unstructured":"Bjorling E, Scarlatti G, von Gegerfelt A, Albert J, Biberfeld G, Chiodi F, Norrby E, Fenyo EM: Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology. 1993, 193: 528-530. 10.1006\/viro.1993.1160.","journal-title":"Virology"},{"key":"903_CR35","first-page":"11","volume":"3","author":"S Andersson","year":"2001","unstructured":"Andersson S: HIV-2 and the immune response. AIDS Reviews. 2001, 3: 11-23.","journal-title":"AIDS Reviews"},{"key":"903_CR36","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1099\/vir.0.81259-0","volume":"86","author":"Y Shi","year":"2005","unstructured":"Shi Y, Brandin E, Vincic E, Jansson M, Blaxhult A, Gyllensten K, Moberg L, Brostrom C, Fenyo EM, Albert J: Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation. J Gen Virol. 2005, 86: 3385-3396. 10.1099\/vir.0.81259-0.","journal-title":"J Gen Virol"},{"key":"903_CR37","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1128\/JVI.02789-06","volume":"81","author":"SK Rodriguez","year":"2007","unstructured":"Rodriguez SK, Sarr AD, MacNeil A, Thakore-Meloni S, Gueye-Ndiaye A, Traore I, Dia MC, Mboup S, Kanki PJ: Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections. J Virol. 2007, 81: 5331-5338. 10.1128\/JVI.02789-06.","journal-title":"J Virol"},{"key":"903_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<111::AID-JMV18>3.0.CO;2-W","volume":"61","author":"V Soriano","year":"2000","unstructured":"Soriano V, Gomes P, Heneine W, Holguin A, Doruana M, Antunes R, Mansinho K, Switzer WM, Araujo C, Shanmugam V, et al: Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J Med Virol. 2000, 61: 111-116. 10.1002\/(SICI)1096-9071(200005)61:1<111::AID-JMV18>3.0.CO;2-W.","journal-title":"J Med Virol"},{"key":"903_CR39","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/JVI.72.4.3418-3422.1998","volume":"72","author":"P Cavaco-Silva","year":"1998","unstructured":"Cavaco-Silva P, Taveira NC, Rosado L, Lourenco MH, Moniz-Pereira J, Douglas NW, Daniels RS, Santos-Ferreira MO: Virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmission. J Virol. 1998, 72: 3418-3422.","journal-title":"J Virol"},{"key":"903_CR40","volume-title":"Molecular cloning: a laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Maniatis T, Fritsch EF: Molecular cloning: a laboratory manual. 1989, Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 2","edition":"2"},{"key":"903_CR41","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1093\/nar\/25.24.4876","volume":"25","author":"JD Thompson","year":"1997","unstructured":"Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25: 4876-4882. 10.1093\/nar\/25.24.4876.","journal-title":"Nucleic Acids Res"},{"key":"903_CR42","volume-title":"GeneDoc: a tool for editing and annotating multiple sequence alignments. Distributed by the author","author":"KB Nicholas","year":"1997","unstructured":"Nicholas KB, Nicholas Hugh B: GeneDoc: a tool for editing and annotating multiple sequence alignments. Distributed by the author. 1997"},{"key":"903_CR43","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/molbev\/msm092","volume":"24","author":"K Tamura","year":"2007","unstructured":"Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24: 1596-1599. 10.1093\/molbev\/msm092.","journal-title":"Mol Biol Evol"},{"key":"903_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF01734359","volume":"17","author":"J Felsenstein","year":"1981","unstructured":"Felsenstein J: Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol. 1981, 17: 368-376. 10.1007\/BF01734359.","journal-title":"J Mol Evol"},{"key":"903_CR45","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/bioinformatics\/14.9.817","volume":"14","author":"D Posada","year":"1998","unstructured":"Posada D, Crandall KA: MODELTEST: testing the model of DNA substitution. Bioinformatics. 1998, 14: 817-818. 10.1093\/bioinformatics\/14.9.817.","journal-title":"Bioinformatics"},{"key":"903_CR46","volume-title":"PAUP*. Phylogenetic Analysis using Parsimony (*and other Methods). Version 4.","author":"DL Swofford","year":"1998","unstructured":"Swofford DL: PAUP*. Phylogenetic Analysis using Parsimony (*and other Methods). Version 4. 1998, Sinauer-Associates, Sunderland, Massachusetts"},{"key":"903_CR47","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2307\/2408678","volume":"39","author":"J Felsenstein","year":"1985","unstructured":"Felsenstein J: Confidence limits on phylogenies: An approach using the bootstrap. Evolution. 1985, 39: 783-791. 10.2307\/2408678.","journal-title":"Evolution"},{"key":"903_CR48","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JVI.02660-07","volume":"82","author":"JF Salazar-Gonzalez","year":"2008","unstructured":"Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, et al: Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol. 2008, 82: 3952-3970. 10.1128\/JVI.02660-07.","journal-title":"J Virol"},{"key":"903_CR49","unstructured":"Branchlength Calculator. [http:\/\/www.hiv.lanl.gov\/content\/sequence\/BRANCHLENGTH\/branchlength.html]"},{"key":"903_CR50","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/bioinformatics\/bti079","volume":"21","author":"SL Pond","year":"2005","unstructured":"Pond SL, Frost SD, Muse SV: HyPhy: hypothesis testing using phylogenies. Bioinformatics. 2005, 21: 676-679. 10.1093\/bioinformatics\/bti079.","journal-title":"Bioinformatics"},{"key":"903_CR51","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/glycob\/cwh106","volume":"14","author":"M Zhang","year":"2004","unstructured":"Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C, Korber B: Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology. 2004, 14: 1229-1246. 10.1093\/glycob\/cwh106.","journal-title":"Glycobiology"},{"key":"903_CR52","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1128\/jvi.68.11.7467-7481.1994","volume":"68","author":"BT Korber","year":"1994","unstructured":"Korber BT, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, Wolinsky SM: Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol. 1994, 68: 7467-7481.","journal-title":"J Virol"},{"key":"903_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1128\/JCM.44.2.607-611.2006","volume":"44","author":"JM Marcelino","year":"2006","unstructured":"Marcelino JM, Barroso H, Goncalves F, Silva SM, Novo C, Gomes P, Camacho R, Taveira N: Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins. J Clin Microbiol. 2006, 44: 607-611. 10.1128\/JCM.44.2.607-611.2006.","journal-title":"J Clin Microbiol"},{"key":"903_CR54","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.4049\/jimmunol.147.9.3128","volume":"147","author":"P Botarelli","year":"1991","unstructured":"Botarelli P, Houlden BA, Haigwood NL, Servis C, Montagna D, Abrignani S: N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. J Immunol. 1991, 147: 3128-3132.","journal-title":"J Immunol"},{"key":"903_CR55","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1099\/vir.0.81510-0","volume":"87","author":"P Clevestig","year":"2006","unstructured":"Clevestig P, Pramanik L, Leitner T, Ehrnst A: CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site. J Gen Virol. 2006, 87: 607-612. 10.1099\/vir.0.81510-0.","journal-title":"J Gen Virol"},{"key":"903_CR56","doi-asserted-by":"publisher","first-page":"13433","DOI":"10.1074\/jbc.M009779200","volume":"276","author":"G Pollakis","year":"2001","unstructured":"Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, Paxton WA: N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem. 2001, 276: 13433-13441. 10.1074\/jbc.M009779200.","journal-title":"J Biol Chem"},{"key":"903_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/viro.2002.1760","volume":"304","author":"S Polzer","year":"2002","unstructured":"Polzer S, Dittmar MT, Schmitz H, Schreiber M: The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology. 2002, 304: 70-80. 10.1006\/viro.2002.1760.","journal-title":"Virology"},{"key":"903_CR58","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1086\/518935","volume":"196","author":"B Joos","year":"2007","unstructured":"Joos B, Fischer M, Schweizer A, Kuster H, Boni J, Wong JK, Weber R, Trkola A, Gunthard HF: Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regions. J Infect Dis. 2007, 196: 313-320. 10.1086\/518935.","journal-title":"J Infect Dis"},{"key":"903_CR59","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1089\/aid.2004.20.1373","volume":"20","author":"H Barroso","year":"2004","unstructured":"Barroso H, Araujo F, Gomes MH, Mota-Miranda A, Taveira N: Phylogenetic demonstration of two cases of perinatal human immunodeficiency virus type 2 infection diagnosed in adulthood. AIDS Res Hum Retroviruses. 2004, 20: 1373-1376. 10.1089\/aid.2004.20.1373.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"903_CR60","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrg1246","volume":"5","author":"A Rambaut","year":"2004","unstructured":"Rambaut A, Posada D, Crandall KA, Holmes EC: The causes and consequences of HIV evolution. Nat Rev Genet. 2004, 5: 52-61. 10.1038\/nrg1246.","journal-title":"Nat Rev Genet"},{"key":"903_CR61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/JCM.37.2.453-456.1999","volume":"37","author":"P Gomes","year":"1999","unstructured":"Gomes P, Taveira NC, Pereira JM, Antunes F, Ferreira MO, Lourenco MH: Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay. J Clin Microbiol. 1999, 37: 453-456.","journal-title":"J Clin Microbiol"},{"key":"903_CR62","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1046\/j.1365-2249.1999.00914.x","volume":"116","author":"O Jobe","year":"1999","unstructured":"Jobe O, Ariyoshi K, Marchant A, Sabally S, Corrah T, Berry N, Jaffar S, Whittle H: Proviral load and immune function in blood and lymph node during HIV-1 and HIV-2 infection. Clin Exp Immunol. 1999, 116: 474-478. 10.1046\/j.1365-2249.1999.00914.x.","journal-title":"Clin Exp Immunol"},{"key":"903_CR63","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1089\/08892220050117069","volume":"16","author":"R Parreira","year":"2000","unstructured":"Parreira R, Esteves A, Santos C, Piedade J, Venenno T, Canas-Ferreira WF: Genetic variability of human immunodeficiency virus type 2 C2V3 region within and between individuals from Bissau, Guinea-Bissau, West Africa. AIDS Res Hum Retroviruses. 2000, 16: 1307-1312. 10.1089\/08892220050117069.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"903_CR64","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1128\/JVI.74.9.4335-4350.2000","volume":"74","author":"Y Yamaguchi-Kabata","year":"2000","unstructured":"Yamaguchi-Kabata Y, Gojobori T: Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J Virol. 2000, 74: 4335-4350. 10.1128\/JVI.74.9.4335-4350.2000.","journal-title":"J Virol"},{"key":"903_CR65","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00239-003-2467-9","volume":"57","author":"W Yang","year":"2003","unstructured":"Yang W, Bielawski JP, Yang Z: Widespread adaptive evolution in the human immunodeficiency virus type 1 genome. J Mol Evol. 2003, 57: 212-221. 10.1007\/s00239-003-2467-9.","journal-title":"J Mol Evol"},{"key":"903_CR66","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.pcbi.0030029","volume":"3","author":"P Lemey","year":"2007","unstructured":"Lemey P, Kosakovsky Pond SL, Drummond AJ, Pybus OG, Shapiro B, Barroso H, Taveira N, Rambaut A: Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol. 2007, 3: e29-10.1371\/journal.pcbi.0030029.","journal-title":"PLoS Comput Biol"},{"key":"903_CR67","doi-asserted-by":"publisher","first-page":"11715","DOI":"10.1128\/JVI.76.22.11715-11720.2002","volume":"76","author":"HA Ross","year":"2002","unstructured":"Ross HA, Rodrigo AG: Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol. 2002, 76: 11715-11720. 10.1128\/JVI.76.22.11715-11720.2002.","journal-title":"J Virol"},{"key":"903_CR68","unstructured":"Korber M BT, Brander C, Haynes BF, Koup R, Moore JP, Walker BD, Watkins DI: HIV Molecular Immunology 2006\/2007. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, New Mexico. LA-UR 07-4752."},{"key":"903_CR69","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/nature05818","volume":"446","author":"CN Scanlan","year":"2007","unstructured":"Scanlan CN, Offer J, Zitzmann N, Dwek RA: Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature. 2007, 446: 1038-1045. 10.1038\/nature05818.","journal-title":"Nature"},{"key":"903_CR70","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1128\/jvi.70.10.7143-7152.1996","volume":"70","author":"PB Fischer","year":"1996","unstructured":"Fischer PB, Karlsson GB, Butters TD, Dwek RA, Platt FM: N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1\/V2 region of gp120. J Virol. 1996, 70: 7143-7152.","journal-title":"J Virol"},{"key":"903_CR71","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1371\/journal.pcbi.0030011","volume":"3","author":"AF Poon","year":"2007","unstructured":"Poon AF, Lewis FI, Pond SL, Frost SD: Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope. PLoS Comput Biol. 2007, 3: e11-10.1371\/journal.pcbi.0030011.","journal-title":"PLoS Comput Biol"},{"key":"903_CR72","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1126\/science.1090727","volume":"303","author":"BT Grenfell","year":"2004","unstructured":"Grenfell BT, Pybus OG, Gog JR, Wood JL, Daly JM, Mumford JA, Holmes EC: Unifying the epidemiological and evolutionary dynamics of pathogens. Science. 2004, 303: 327-332. 10.1126\/science.1090727.","journal-title":"Science"},{"key":"903_CR73","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nri1307","volume":"4","author":"S Zolla-Pazner","year":"2004","unstructured":"Zolla-Pazner S: Identifying epitopes of HIV-1 that induce protective antibodies. Nat Rev Immunol. 2004, 4: 199-210. 10.1038\/nri1307.","journal-title":"Nat Rev Immunol"},{"key":"903_CR74","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1073\/pnas.0630530100","volume":"100","author":"DD Richman","year":"2003","unstructured":"Richman DD, Wrin T, Little SJ, Petropoulos CJ: Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA. 2003, 100: 4144-4149. 10.1073\/pnas.0630530100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"903_CR75","doi-asserted-by":"publisher","first-page":"18514","DOI":"10.1073\/pnas.0504658102","volume":"102","author":"SD Frost","year":"2005","unstructured":"Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, Paxinos E, Chappey C, Galovich J, Beauchaine J, Petropoulos CJ, et al: Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci USA. 2005, 102: 18514-18519. 10.1073\/pnas.0504658102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"903_CR76","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1128\/JVI.02187-07","volume":"82","author":"PL Moore","year":"2008","unstructured":"Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L: The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J Virol. 2008, 82: 1860-1869. 10.1128\/JVI.02187-07.","journal-title":"J Virol"},{"key":"903_CR77","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/molbev\/msg144","volume":"20","author":"S Williamson","year":"2003","unstructured":"Williamson S: Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol Biol Evol. 2003, 20: 1318-1325. 10.1093\/molbev\/msg144.","journal-title":"Mol Biol Evol"},{"key":"903_CR78","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1099\/vir.0.81391-0","volume":"87","author":"D Marchant","year":"2006","unstructured":"Marchant D, Neil SJ, McKnight A: Human immunodeficiency virus types 1 and 2 have different replication kinetics in human primary macrophage culture. J Gen Virol. 2006, 87: 411-418. 10.1099\/vir.0.81391-0.","journal-title":"J Gen Virol"},{"key":"903_CR79","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0042-6822(02)00088-0","volume":"308","author":"Q Lizeng","year":"2003","unstructured":"Lizeng Q, Skott P, Sourial S, Nilsson C, Andersson SS, Ehnlund M, Taveira N, Bjorling E: Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection. Virology. 2003, 308: 225-232. 10.1016\/S0042-6822(02)00088-0.","journal-title":"Virology"},{"key":"903_CR80","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1128\/jvi.71.10.7719-7727.1997","volume":"71","author":"B Chackerian","year":"1997","unstructured":"Chackerian B, Rudensey LM, Overbaugh J: Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J Virol. 1997, 71: 7719-7727.","journal-title":"J Virol"},{"key":"903_CR81","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, et al: Antibody neutralization and escape by HIV-1. Nature. 2003, 422: 307-312. 10.1038\/nature01470.","journal-title":"Nature"},{"key":"903_CR82","doi-asserted-by":"publisher","first-page":"9586","DOI":"10.1128\/JVI.00141-06","volume":"80","author":"M Sagar","year":"2006","unstructured":"Sagar M, Wu X, Lee S, Overbaugh J: Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol. 2006, 80: 9586-9598. 10.1128\/JVI.00141-06.","journal-title":"J Virol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-5-78.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T22:03:37Z","timestamp":1684533817000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-5-78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,8]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-5-78","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,8]]},"assertion":[{"value":"29 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"78"}}